Insider · CIK 0001638709
Sandra Horning
Files at GILD (GILEAD SCIENCES, INC.), RVMD (Revolution Medicines, Inc.), MRNA (Moderna, Inc.), OLMA (Olema Pharmaceuticals, Inc.), EQRX (EQRx, Inc.). First filing -, latest -.
In brief
Sandra Horning files SEC Form 4 as director at GILD (GILEAD SCIENCES, INC.), and also at RVMD (Revolution Medicines, Inc.), MRNA (Moderna, Inc.), OLMA (Olema Pharmaceuticals, Inc.), EQRX (EQRx, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sandra Horning has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 35 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +29,500 | $0.00 | $0 | 29,500 | Jun 23, 2026 |
| Jun 18, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +1,191 | $0.00 | $0 | 97,765 | Jun 23, 2026 |
| Jun 18, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,127 | $0.00 | $0 | 3,127 | Jun 23, 2026 |
| May 6, 2026 | MRNA Moderna, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +9,681 | $0.00 | $0 | 9,681 | May 8, 2026 |
| May 6, 2026 | MRNA Moderna, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,092 | $0.00 | $0 | 2,092 | May 8, 2026 |
| Apr 30, 2026 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +1,146 | $0.00 | $0 | 6,293 | May 4, 2026 |
| Apr 30, 2026 | MRNA Moderna, Inc. | MOption exercise Common Stock | +16,233 | - | - | 18,585 | May 4, 2026 |
| Apr 30, 2026 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +4,884 | $0.00 | $0 | 4,884 | May 4, 2026 |
| Apr 30, 2026 | MRNA Moderna, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,233 | $0.00 | $0 | 0 | May 4, 2026 |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +3,142 | $0.00 | $0 | 96,574 | Jun 30, 2025 |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,574 | $0.00 | $0 | 11,574 | Jun 30, 2025 |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +24,150 | $0.00 | $0 | 24,150 | Jun 13, 2025 |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +1,516 | $0.00 | $0 | 5,147 | May 8, 2025 |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +6,809 | $0.00 | $0 | 6,809 | May 8, 2025 |
| Apr 30, 2025 | MRNA Moderna, Inc. | MOption exercise Common Stock | +979 | - | - | 2,352 | May 1, 2025 |
| Apr 30, 2025 | MRNA Moderna, Inc. | MOption exercise Restricted Stock Unitsderivative | -979 | $0.00 | $0 | 0 | May 1, 2025 |
| Apr 30, 2025 | MRNA Moderna, Inc. | AGrant or award Restricted Stock Unitsderivative | +16,233 | $0.00 | $0 | 16,233 | May 1, 2025 |
| Jun 20, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +2,945 | $0.00 | $0 | 93,432 | Jun 28, 2024 |
| Jun 20, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,248 | $0.00 | $0 | 10,248 | Jun 28, 2024 |
| Jun 20, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +4,800 | $0.00 | $0 | 95,287 | Jun 24, 2024 |
| Jun 20, 2024 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,700 | $0.00 | $0 | 16,700 | Jun 24, 2024 |
| Jun 14, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +23,000 | $0.00 | $0 | 23,000 | Jun 18, 2024 |
| May 8, 2024 | GILD GILEAD SCIENCES, INC. | AGrant or award Restricted Stock Unitderivative | +2,310 | - | - | 7,801 | May 9, 2024 |
| May 8, 2024 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +12,648 | $0.00 | $0 | 12,648 | May 9, 2024 |
| May 6, 2024 | MRNA Moderna, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,668 | $0.00 | $0 | 5,668 | May 7, 2024 |
| May 6, 2024 | MRNA Moderna, Inc. | AGrant or award Restricted Stock Unitsderivative | +979 | $0.00 | $0 | 979 | May 7, 2024 |
| Nov 9, 2023 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +52,291 | - | - | 52,291 | Nov 14, 2023 |
| Nov 9, 2023 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +27,696 | - | - | 79,987 | Nov 14, 2023 |
| Nov 9, 2023 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +10,500 | $0.00 | $0 | 90,487 | Nov 14, 2023 |
| Nov 9, 2023 | RVMD Revolution Medicines, Inc. | AGrant or award Earn-out Sharesderivative | +10,651 | - | - | 10,651 | Nov 14, 2023 |
| Nov 9, 2023 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,800 | $0.00 | $0 | 36,800 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | DDisposition to issuer Common Stock | -470,250 | - | - | 0 | Nov 9, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -313,500 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 9, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | DDisposition to issuer Earn-out Sharesderivative | -107,929 | - | - | 0 | Nov 9, 2023 |
Questions about Sandra Horning
Answered from the filings on this page, as of the latest one.
Is Sandra Horning buying or selling?
Sandra Horning has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sandra Horning's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sandra Horning has 0.
Where does Sandra Horning file Form 4?
Sandra Horning has filed Form 4 at GILD (GILEAD SCIENCES, INC.); RVMD (Revolution Medicines, Inc.); MRNA (Moderna, Inc.); OLMA (Olema Pharmaceuticals, Inc.); EQRX (EQRx, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.